Research Article |
Corresponding author: Yesi Desmiaty ( yesi.desmiaty@univpancasila.ac.id ) Academic editor: Rumiana Simeonova
© 2023 Ni Made Dwi Sandhiutami, Yesi Desmiaty, Yati Sumiyati, Asma Fauziyah Baihaqi, Myra Gracia.
This is an open access article distributed under the terms of the Creative Commons Attribution License (CC BY 4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Citation:
Sandhiutami NMD, Desmiaty Y, Sumiyati Y, Baihaqi AF, Gracia M (2023) The potential of Colocasia esculenta tuber and Zingiber officinale rhizome combined extracts to ameliorate inflammation in monosodium iodoacetate-osteoarthritis rat model. Pharmacia 70(4): 1295-1303. https://doi.org/10.3897/pharmacia.70.e111415
|
This study aims to evaluate effect of Colocasia esculenta and Zingiber officinale combined extract (CEZO) in osteoarthritis rats. Twenty-four Wistar rats were split into normal group, positive group, negative group, and CEZO group on 29th to 43rd day (n = 6). All rats were injected with Na-iodoacetate intraarticularly on first day, unless for the normal group, and then observing the diameter of knee edema until the 28th day (OA rats). On the 43rd day, rats were euthanasia for measurements of hematology, spleen weight, and inflammatory mediators of nitric oxide, matrix metalloproteinase 9, Interleukin-6, and tumor necrosis factor-α using ELISA kit. Our experiments showed that CEZO 90 mg/kgBW was able to decrease knee edema, leukocytes, lymphocytes, spleen enlargement, the concentration of mediators inflammatory NO, TNF-α, IL-6, and protect cartilage degradation by decreased MMP-9 significantly in OA rats. Conclusion of the research is the CEZO 90 mg/kgBW supplementation has potential to be used in osteoarthritis.
Nitric Oxide, TNF-α, IL-6, in-vivo, combination extract
Osteoarthritis (OA) is the most frequent chronic joint illness(
Jamu is an Indonesian traditional herbal remedy, that has been used empirically by Indonesians as an alternative therapy for variety of illness such as OA because it is thought to less hazardous and has fewer adverse reaction (
There is a lack of studies to examine the effect of Colocasia esculenta tuber and Zingiber officinale rhizome combined extract (CEZO) on OA by measuring the levels of its biomarkers, namely NO, IL-6, TNF-α, and MMP-9. So, this research aimed to scientifically prove the potency of CEZO in rats with OA induced using MIA, so that this research can provide great benefits to patients with OA.
CE aqueous extracts, ZO aqueous extracts, monosodium-Iodoacetate (Sigma-Aldrich), Xylazine (Interchemie, Holland), Ketamin HCl Injection, USP (Hospira, Inc., USA), Sodium diclofenac tablets 25 mg (Novell, Indonesia), NO, IL-6, TNF-α, and MMP-9 Elisa Kit (RnD Systems, USA), 10,000 Molecular weight cut-off filters (Millipore), NaCl 0,9%, CMC Na, and Ethanol (Brataco Chemical, Indonesia).
This experiment was carried out from July to December 2022. These assays were approved and conducted after receiving ethical approval from the Ethics Committee of Health Research, Medicine Faculty, Universitas Indonesia (No. 1419/UN2F1/ETIK/PPM00.02/2022). Rats that were used were acclimatized for one week with controlled room condition 25 ± 2 °C, moisture 65 ± 10%, illumination 12 hrs per day (07:00 – 19:00), and air ventilation 11–13 times per day. The rats were given regular pellets and ad libitum drinking.
Sodium carboxymethylcellulose (Na-CMC) suspension was prepared by weighing as much as 0.5% of the desired dosage volume, then add hot distilled water at 70 °C. Allow Na-CMC to swell for 10–15 minutes then grind until homogeneous. Each 500 mg of extract contains 350 mg of CE and 150 mg of ZO. Add the combined CE and ZO extracts and suspend with 0.5% Na-CMC suspension. Sodium diclofenac suspension was prepared by suspending crushed diclofenac tablets into 0.5% Na-CMC for a dose equivalent to 150 mg/day (
In this test, 24 male Wistar rats were acclimatized, then split into 4 sets, each consisting of six rats as follows: Normal group as the control without any treatment, Positive control group given sodium diclofenac suspension 13.5 mg/kgBW, Negative group given sodium CMC (0.5%), and sample group was given CEZO suspension at a dose of 90 mg/kgBW given orally using oral sonde. All the groups were injected with 0.025 mL MIA (10 mg/mL) intra-articularly on day 1 and then observing it until the 28th day, except the normal group. Induction of OA with 0.025 ml (10 mg/mL) intra-articular injection MIA was performed by anesthetizing rats with a combination of xylazine at dose 8.8 mg/kgBW and ketamine (75 mg/kgBW) intraperitoneally. Inject 0.025 ml (10 mg/mL) MIA with the needle to the area that has been marked and massage the knee gently to ensure that the injected MIA solution is distributed evenly (
Blood was placed in a clean tube and had been given K3EDTA for leukocyte and lymphocyte count levels, then measured automatically using a Sysmax XS-1000i Hematology analyzer with the principle of Flow cytometry. The blood allowed to stand until it clots (30 min) at room condition and then centrifuged (5 min, 3500 rpm). Transfer the serum to a new tube and store it at ≤ 20 °C before measuring.
Measurement of the spleen weight was carried out by taking the spleen through the abdominal section of the rat. After the spleen organ is taken, it is weighed using a scale, then calculate the mean of each group (
Knee tissue is taken and isolation of proteins from knee tissue using 10xRIPA buffer pH 7.4 (150 mM sodium chloride, 50 mM Tris-HCl, 1% NP-40, 0.25% Na-deoxycholate, 1 mM NaF, and 1 mM Na3VO4). The isolate was stored at –40 °C for analysis. Measurement of proinflammatory mediators IL-6, TNF-α, NO, and MMP-9 was conducted using an ELISA kit. The manufacturer’s procedure was followed for conducting the analysis to measure absorbance using a microplate reader spectrophotometer (Bio-Rad Reader 680).
Parameter measurement data from each treatment group were statistically analyzed using SPSS 20. The Shapiro-Wilk normality test and Levene homogeneity test were carried out followed by a parametric statistical test using the ANOVA method, then proceed with the Post HOC Least Square Difference (LSD) test. The significant degree value used was with a 95% confidence interval (p < 0.05).
In this study, the OA model with Monosodium Iodoacetate (MIA) induced was successful after 28 days from the first injection of MIA in the joint of the rat intraarticular (Fig.
When cartilage deteriorates to the point where the cartilage rubs against one another, edema can occur. In this study, within 28 days after intraarticular injection of MIA it appeared that increase in the diameter of knee edema in the positive and treatment group, and then continue to reduce the volume of edema until day 43rd. These results were linear with another study which showed that the rat model of osteoarthritis MIA-induced showed signs of inflammation in the form of increased levels of leukocytes, lymphocytes, and spleen weight (
Measurements of the edema caused by inflammation were done on days 0, 7th, 14th, 28th, 36th, and 43rd. Measurements were made to assess changes in edema diameter in the treatment group. Fig.
Table
Hematology | Unit | Normal group | Negative control group | Positive control group | CEZO group |
---|---|---|---|---|---|
Leukocyte (WBC) | 103/µL | 15.96 ± 4.62 | 18.54 ± 5.93* | 16.08 ± 3.89# | 16.60 ± 3.31# |
Lymphocytes | % | 68.00 ± 15.25 | 73.25 ± 9.33* | 65.50 ± 17.08# | 68.25 ± 7.74# |
Neutrophils | % | 26.33 ± 11.09 | 40.67 ± 6.77* | 32.83 ± 20.01# | 27.67 ± 9.00# |
Red Blood Cells (RBC) | 103/µL | 7.29 ± 1.25 | 8.2 ± 0.39 | 7.78 ± 0.94 | 7.85 ± 1.03 |
Hb | g/dL | 14.50 ± 2.54 | 15.4 ± 0.48 | 13.68 ± 1.38 | 14.78 ± 1.22 |
Hct | % | 41.25 ± 5.12 | 42.12 ± 1.26 | 38.23 ± 3.76 | 41.77 ± 3.87 |
MCV | fL | 57.25 ± 6.87 | 51.45 ± 2.95 | 49.92 ± 1.41 | 53.47 ± 2.97 |
MCH | pg | 19.88 ± 0.63 | 18.82 ± 0.97 | 17.87 ± 0.55 | 18.93 ± 1.12 |
MCHC | g/dL | 35.07 ± 3.56 | 36.58 ± 0.74 | 35.80 ± 0.47 | 35.43 ± 0.54 |
Thrombocyte | 103/µL | 741.33 ± 91.43 | 788.5 ± 52.94 | 786.00 ± 105.94 | 783.67 ± 114.85 |
RDW | % | 13.27 ± 2.15 | 13.15 ± 0.90 | 13.78 ± 0.83 | 13.35 ± 1.60 |
MPV | fL | 5.35 ± 0.16 | 5.33 ± 0.15 | 5.18 ± 0.08 | 5.28 ± 0.13 |
PDW | % | 15.82 ± 0.60 | 15.43 ± 0.19 | 15.45 ± 0.44 | 15.77 ± 0.48 |
In addition to producing enzymes that break down cartilage and harm the cartilage matrix, monosodium iodoacetate has enhanced the release of cytokines into the joint cavity, including TNF-alpha, interleukin-1, and interleukin-6 (
The spleen distributes lymphocytes and leukocyte maturation throughout the body via the lymph nodes. As indicated in Table
Group | Weight of spleen (mg) |
---|---|
Normal control group | 0.47 ± 0.06 |
Negative control group | 0.84 ± 0.03* |
Positive control group | 0.58 ± 0.02# |
CEZO group | 0.60 ± 0.03# |
CEZO causes a significant decrease in NO rat’s serum. Fig.
Fig.
Fig.
An influx of inflammatory cells and fluid entered the inflamed area as a result of the joint inflammation. IL-6 in OA pathology plays a role in osteoclast differentiation, and bone resorption also stimulates the production of receptor activators for NF-𝜅B ligand, IL-1β, parathyroid hormone, and its related proteins, as well as PGE-2 (
Fig.
The CEZO retrieved a significant quantity of MMP-9 in this investigation to stop cartilage breakdown during OA. MMP-9 is a type of MMP that plays a role in excessive joint degradation in OA patients. Increased levels of MMP-9 caused by proinflammatory cytokines such as TNF-α and IL-6 stimulate chondrocytes to produce MMP (
In conclusion, this study showed that the combination of C. esculenta tuber and Z. officinale rhizome extracts can reduce inflammation by decreasing pro-inflammatory mediators NO, IL-6, and TNF-α and reducing cartilage degradation by recovering MMP-9 in OA rats induced monosodium iodoacetate. Reduction of pro-inflammatory mediators by CEZO as well as diclofenac. Further investigations are underway in our research team to address the precise mechanisms involved for effective and safe usage.
All authors affirm that there are no conflicts of interest.
This work was funded by Kementerian Riset Teknologi Dan Pendidikan Tinggi Republik Indonesia, Republic of Indonesia in the Grant scheme Matching Fund (MF) 2022 with agreement number PKS: 243/E1/KS/06.02/2022. We would like to thank PT. Titan Pilar Utama Niaga, for providing the combination of C. esculenta and Z. officinale extract.